These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28750419)

  • 1. Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
    Boettger S; Knöpfel S; Schubert M; Garcia Nuñez D; Plichta MM; Klaghofer R; Jenewein J
    Swiss Med Wkly; 2017; 147():w14471. PubMed ID: 28750419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
    Rea RS; Battistone S; Fong JJ; Devlin JW
    Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium: Randomized Controlled Trial.
    Zakhary T; Ahmed I; Luttfi I; Montasser M
    Neurocrit Care; 2024 Oct; 41(2):550-557. PubMed ID: 38561588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.
    Lacasse H; Perreault MM; Williamson DR
    Ann Pharmacother; 2006 Nov; 40(11):1966-73. PubMed ID: 17047137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting.
    Bohny P; Boettger S; Jenewein J
    Front Psychiatry; 2023; 14():1257755. PubMed ID: 37854439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole and haloperidol in the treatment of delirium.
    Boettger S; Friedlander M; Breitbart W; Passik S
    Aust N Z J Psychiatry; 2011 Jun; 45(6):477-82. PubMed ID: 21563866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopharmalogical treatment of delirium in the elderly].
    Drach LM
    Med Monatsschr Pharm; 2014 Apr; 37(4):124-31; quiz 133-4. PubMed ID: 24779187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics in the treatment of delirium.
    Wang HR; Woo YS; Bahk WM
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):323-31. PubMed ID: 23859663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of risperidone in treating the hyperactive symptoms of delirium.
    Liu CY; Juang YY; Liang HY; Lin NC; Yeh EK
    Int Clin Psychopharmacol; 2004 May; 19(3):165-8. PubMed ID: 15107660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
    Briskman I; Dubinski R; Barak Y
    Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-related problems of antipsychotics in treating delirium among elderly patients: A real-world observational study.
    Jenraumjit R; Somboon J; Chainan S; Chuenchom P; Wongpakaran N; Wongpakaran T
    J Clin Pharm Ther; 2021 Oct; 46(5):1274-1280. PubMed ID: 33768628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of delirium in supportive and palliative care.
    Gagnon PR
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):60-6. PubMed ID: 18685397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review.
    Grover S; Mattoo SK; Gupta N
    Pharmacopsychiatry; 2011 Mar; 44(2):43-54. PubMed ID: 21394715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?
    Devlin JW; Skrobik Y
    Harv Rev Psychiatry; 2011; 19(2):59-67. PubMed ID: 21425934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of haloperidol, non-haloperidol antipsychotics, and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population.
    Felton MA; Jarrett JB; Hoffmaster R; D'Amico FJ; Sakely H; Pruskowski J
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):141-148. PubMed ID: 31066639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.